Challenge #5 (part 2)
Look at the scans and answer the multiple choice questions below.
![](https://static.wixstatic.com/media/bcdc3a_7eda07748f144dbcb7a8672fcfcb8449.jpg/v1/fill/w_591,h_680,al_c,q_85,enc_auto/bcdc3a_7eda07748f144dbcb7a8672fcfcb8449.jpg)
![](https://static.wixstatic.com/media/bcdc3a_927f88b67be14fdeaa6a2a8dd751fa96.jpg/v1/fill/w_591,h_680,al_c,q_85,enc_auto/bcdc3a_927f88b67be14fdeaa6a2a8dd751fa96.jpg)
![](https://static.wixstatic.com/media/bcdc3a_03deaf9061824c30b99eef3ba707832b.jpg/v1/fill/w_591,h_680,al_c,q_85,enc_auto/bcdc3a_03deaf9061824c30b99eef3ba707832b.jpg)
1. What combination of findings suggests recurrent tumor over treatment effect?
a) Increased diffusivity and increased perfusion
b) Decreased diffusivity and increased perfusion
c) Increased diffusivity and decreased perfusion
d) Decreased diffusivity and decreased perfusion
2. What impact does an anti-VEGF agent like Avastin on perfusion?
a) No impact
b) Increased perfusion
c) Decreased perfusion
d) All of the above
3. What impact does Temodar have on perfusion?
a) No impact
b) Increased perfusion
c) Decreased perfusion
d) All of the above
Be sure to submit your answers for a chance to win a special prize!